Joy Bessenger
Finanzdirektor/CFO bei TRELLUS HEALTH PLC
Aktive Positionen von Joy Bessenger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRELLUS HEALTH PLC | Finanzdirektor/CFO | 18.09.2023 | - |
Karriereverlauf von Joy Bessenger
Ehemalige bekannte Positionen von Joy Bessenger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMV INC. | Investor Relations Kontakt | 01.09.2021 | 11.06.2022 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Public Communications Contact | 26.06.2009 | - |
Ausbildung von Joy Bessenger
| University of South Florida | Undergraduate Degree |
Statistik
International
| Island | 2 |
| Kanada | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Public Communications Contact | 1 |
| Investor Relations Contact | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMV INC. | Health Technology |
| TRELLUS HEALTH PLC | Technology Services |
| Private Unternehmen | 1 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Börse
- Insiders
- Joy Bessenger
- Erfahrung
